Impact of ABCG2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients

C. Lemos, E. Giovannetti, P.A. Zucali, Y.G. Assaraf, G.L. Scheffer, T. van der Straaten, A. D'Incecco, A. Falcone, H.J. Guchelaar, R. Danesi, A. Santoro, G. Giaccone, C. Tibaldi, G.J. Peters

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)159-170
JournalPharmacogenomics
Volume12
Issue number2
DOIs
Publication statusPublished - 2011

Cite this

Lemos, C. ; Giovannetti, E. ; Zucali, P.A. ; Assaraf, Y.G. ; Scheffer, G.L. ; van der Straaten, T. ; D'Incecco, A. ; Falcone, A. ; Guchelaar, H.J. ; Danesi, R. ; Santoro, A. ; Giaccone, G. ; Tibaldi, C. ; Peters, G.J. / Impact of ABCG2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients. In: Pharmacogenomics. 2011 ; Vol. 12, No. 2. pp. 159-170.
@article{9a3e0cb8b37c4956b8aad471c3e9fdc5,
title = "Impact of ABCG2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients",
author = "C. Lemos and E. Giovannetti and P.A. Zucali and Y.G. Assaraf and G.L. Scheffer and {van der Straaten}, T. and A. D'Incecco and A. Falcone and H.J. Guchelaar and R. Danesi and A. Santoro and G. Giaccone and C. Tibaldi and G.J. Peters",
year = "2011",
doi = "10.2217/pgs.10.172",
language = "Undefined/Unknown",
volume = "12",
pages = "159--170",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "2",

}

Lemos, C, Giovannetti, E, Zucali, PA, Assaraf, YG, Scheffer, GL, van der Straaten, T, D'Incecco, A, Falcone, A, Guchelaar, HJ, Danesi, R, Santoro, A, Giaccone, G, Tibaldi, C & Peters, GJ 2011, 'Impact of ABCG2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients' Pharmacogenomics, vol. 12, no. 2, pp. 159-170. https://doi.org/10.2217/pgs.10.172

Impact of ABCG2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients. / Lemos, C.; Giovannetti, E.; Zucali, P.A.; Assaraf, Y.G.; Scheffer, G.L.; van der Straaten, T.; D'Incecco, A.; Falcone, A.; Guchelaar, H.J.; Danesi, R.; Santoro, A.; Giaccone, G.; Tibaldi, C.; Peters, G.J.

In: Pharmacogenomics, Vol. 12, No. 2, 2011, p. 159-170.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Impact of ABCG2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients

AU - Lemos, C.

AU - Giovannetti, E.

AU - Zucali, P.A.

AU - Assaraf, Y.G.

AU - Scheffer, G.L.

AU - van der Straaten, T.

AU - D'Incecco, A.

AU - Falcone, A.

AU - Guchelaar, H.J.

AU - Danesi, R.

AU - Santoro, A.

AU - Giaccone, G.

AU - Tibaldi, C.

AU - Peters, G.J.

PY - 2011

Y1 - 2011

U2 - 10.2217/pgs.10.172

DO - 10.2217/pgs.10.172

M3 - Article

VL - 12

SP - 159

EP - 170

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 2

ER -